<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01522534</url>
  </required_header>
  <id_info>
    <org_study_id>chra-2009-001</org_study_id>
    <nct_id>NCT01522534</nct_id>
  </id_info>
  <brief_title>Randomized Double Blind Controlled Trial Comparing a Blind Sciatic Nerve Block in the Popliteal Fossa to Intravenous Morphine for Traumatic Severe Acute Pain in the Prehospital Setting</brief_title>
  <acronym>BPOP</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier de la Région d'Annecy</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier de la Région d'Annecy</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to determine the efficacity of a simple blind technic of loco
      regional anaesthesia of the sciatic nerve compared to the gold standard in emergency medecine
      : the intravenous morphine for treated the severe pain of leg, ankle or foot trauma in the
      prehospital setting and mountain rescue.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Severe pain due to leg, ankle or foot trauma do not beneficiated of a simple loco regional
      anaesthesia technic. Loco regional anesthesia is superior to intravenous morphine for
      treating severe pain and specially during transportation and mobilization of the patient. The
      purpose of the study is to assessed a new technic of blind sciatic nerve block in the
      popliteal fossa in the pre hospital setting compared to the intravenous morphine. The blind
      technic is a modified technic of the classic sciatic nerve block with nerve stimulation.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2012</start_date>
  <completion_date type="Anticipated">December 2013</completion_date>
  <primary_completion_date type="Anticipated">September 2013</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual analog scale pain score</measure>
    <time_frame>30 minutes</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Total dose of morphine</measure>
    <time_frame>60 minutes</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">66</enrollment>
  <condition>Injuries</condition>
  <condition>Pain</condition>
  <condition>Emergencies</condition>
  <arm_group>
    <arm_group_label>Blind block with mepivacaine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Blind block with mepivacaine and intravenous morphine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Morphine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intravenous Morphine and placebo blind block</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Mepivacaine</intervention_name>
    <description>mepivacaine 1% 20 ml corresponding to 200 mg</description>
    <arm_group_label>Blind block with mepivacaine</arm_group_label>
    <other_name>experimental group</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Morphine</intervention_name>
    <description>Morphine alone with a placebo nerve block</description>
    <arm_group_label>Morphine</arm_group_label>
    <other_name>control group</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Severe pain (VAS &gt; or = 60mm); injuries of the leg, ankle or foot

        Exclusion Criteria:

          -  Hypersensitivity to student agents

          -  Local infection

          -  Nerve or vascular pathology in the affected limb, coagulation pathology,

          -  Chronic use of opoids, use of opoids within 6 hours

          -  Drug addiction

          -  Pregnancy

          -  Systolic blood pressure less than 90 mmHg

          -  Respiratory rate less than 16 per minute

          -  Glasgow coma scale &lt; 14.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Francois Xavier AGERON, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Hospitalier de la Région d'Annecy</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Francois Xavier AGERON, MD</last_name>
    <phone>0033450636444</phone>
    <email>fxageron@ch-annecy.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Centre Hospitalier d'Albertville moutiers</name>
      <address>
        <city>Albertville</city>
        <zip>73208</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Damien Venchiarutti, MD</last_name>
      <phone>0033479895599</phone>
      <email>damien.venchiarutti@wanadoo.fr</email>
    </contact>
    <investigator>
      <last_name>Damien Venchiarutti, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de la Region d'Annecy</name>
      <address>
        <city>Annecy</city>
        <zip>74374</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Francois-Xavier AGERON, MD</last_name>
      <phone>0033450636444</phone>
      <email>fxageron@ch-annecy.fr</email>
    </contact>
    <investigator>
      <last_name>Francois Xavier AGERON, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de Chambéry</name>
      <address>
        <city>Chambery</city>
        <zip>73000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephane Bare, MD</last_name>
      <phone>0033479965050</phone>
      <email>stephane.bare@ch-chambery.fr</email>
    </contact>
    <investigator>
      <last_name>stephane Bare, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire de GRENOBLE</name>
      <address>
        <city>Grenoble</city>
        <zip>38000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Katell Berthelot, MD</last_name>
      <phone>00334 76 63 42 22</phone>
      <email>Kberthelot@chu-grenoble.fr</email>
    </contact>
    <investigator>
      <last_name>Katell Berthelot, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre medical d'Avoriaz</name>
      <address>
        <city>Morzine</city>
        <zip>74110</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>bernard Audema, MD</last_name>
      <phone>0033450740542</phone>
      <email>bernard.audema@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Bernard Audema, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Sallanches Chamonix</name>
      <address>
        <city>Sallanches</city>
        <zip>74700</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>frederic Champly</last_name>
      <phone>0033450473030</phone>
      <email>f.champly@ch-sallanches-chamonix.fr</email>
    </contact>
    <investigator>
      <last_name>Frederic Champly, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 27, 2012</study_first_submitted>
  <study_first_submitted_qc>January 30, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 31, 2012</study_first_posted>
  <last_update_submitted>January 30, 2012</last_update_submitted>
  <last_update_submitted_qc>January 30, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 31, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>injuries</keyword>
  <keyword>pain</keyword>
  <keyword>Block, Nerve</keyword>
  <keyword>morphine</keyword>
  <keyword>Prehospital Emergency Care</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Emergencies</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Morphine</mesh_term>
    <mesh_term>Mepivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

